Merit Medical Systems Total Assets 2006-2021 | MMSI

Merit Medical Systems total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Merit Medical Systems Annual Total Assets
(Millions of US $)
2020 $1,664
2019 $1,757
2018 $1,620
2017 $1,112
2016 $943
2015 $779
2014 $747
2013 $728
2012 $705
2011 $447
2010 $369
2009 $272
2008 $232
2007 $200
2006 $183
2005 $162
Merit Medical Systems Quarterly Total Assets
(Millions of US $)
2021-06-30 $1,642
2021-03-31 $1,652
2020-12-31 $1,664
2020-09-30 $1,671
2020-06-30 $1,716
2020-03-31 $1,749
2019-12-31 $1,757
2019-09-30 $1,762
2019-06-30 $1,736
2019-03-31 $1,690
2018-12-31 $1,620
2018-09-30 $1,310
2018-06-30 $1,291
2018-03-31 $1,239
2017-12-31 $1,112
2017-09-30 $1,087
2017-06-30 $1,052
2017-03-31 $1,015
2016-12-31 $943
2016-09-30 $929
2016-06-30 $815
2016-03-31 $803
2015-12-31 $779
2015-09-30 $768
2015-06-30 $755
2015-03-31 $740
2014-12-31 $747
2014-09-30 $747
2014-06-30 $744
2014-03-31 $742
2013-12-31 $728
2013-09-30 $718
2013-06-30 $728
2013-03-31 $712
2012-12-31 $705
2012-09-30 $519
2012-06-30 $500
2012-03-31 $489
2011-12-31 $447
2011-09-30 $419
2011-06-30 $458
2011-03-31 $380
2010-12-31 $369
2010-09-30 $364
2010-06-30 $280
2010-03-31 $277
2009-12-31 $272
2009-09-30 $265
2009-06-30 $257
2009-03-31 $241
2008-12-31 $232
2008-09-30 $228
2008-06-30 $217
2008-03-31 $211
2007-12-31 $200
2007-09-30 $193
2007-06-30 $191
2007-03-31 $189
2006-12-31 $183
2006-09-30 $177
2006-06-30 $173
2006-03-31 $166
2005-12-31 $162
2005-09-30 $159
2005-06-30 $153
2005-03-31 $146
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.032B $0.964B
Merit Medical Systems, Inc. set out to build the world's most customer-focused healthcare company by understanding customers' needs, and innovating and delivering a diverse range of products that improve the lives of people, families, and communities throughout the world. Merit's primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $75.229B 19.74
Align Technology (ALGN) United States $56.840B 81.93
West Pharmaceutical Services (WST) United States $33.188B 64.09
Straumann Holding AG (SAUHF) Switzerland $32.360B 0.00
McKesson (MCK) United States $32.134B 10.38
Laboratory Of America Holdings (LH) United States $28.528B 8.73
AmerisourceBergen (ABC) United States $25.655B 14.09
Cooper (COO) United States $21.526B 33.28
Cardinal Health (CAH) United States $14.917B 9.47
DENTSPLY SIRONA (XRAY) United States $13.382B 20.62
Henry Schein (HSIC) United States $10.822B 17.69
STAAR Surgical (STAA) United States $6.795B 238.95
CONMED (CNMD) United States $3.792B 42.49
Patterson (PDCO) United States $3.015B 15.34
SmileDirectClub (SDC) United States $2.600B 0.00
Atrion (ATRI) United States $1.332B 42.71
Antares Pharma (ATRS) United States $0.636B 34.00
Retractable Technologies (RVP) United States $0.400B 7.79
Invacare (IVC) United States $0.205B 0.00
Vapor (HCMC) United States $0.204B 0.00
Milestone Scientific (MLSS) United States $0.135B 0.00
Biolase (BIOL) United States $0.104B 0.00
Pro-Dex (PDEX) United States $0.096B 23.57
Lifevantage (LFVN) United States $0.095B 6.86